60 Degrees Pharmaceuticals, Inc. ( SXTP) - Key Metrics
SXTP Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0.08 | -$0.85 | $1.03 | $1.04 |
| 2026Q1 | $0.09 | -$1.21 | -$1.59 | -$1.61 |
| 2025Q4 | $0.26 | -$1.24 | -$1.46 | -$1.57 |
| 2025Q3 | $0.48 | -$2.52 | -$2.30 | -$2.31 |
| 2025Q2 | $0.27 | -$4.71 | -$3.94 | -$4.07 |
SXTP Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -0.49 |
| 2026Q1 | 0% | -0.34 |
| 2025Q4 | 0% | -0.38 |
| 2025Q3 | 0% | -0.59 |
| 2025Q2 | 0% | -0.47 |
SXTP Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q2 | 59.34% | 0% |
| 2026Q1 | -91.77% | 0% |
| 2025Q4 | -77.41% | 0% |
| 2025Q3 | -38.96% | 0% |
| 2025Q2 | -42.90% | 0% |
SXTP
Price: $1.13
52 week price:
Earnings Per Share: -6.76 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 3.2 million